• Boehringer Ingelheim Korea, Clinical Development Director
  • Seoul National University, Public Health, M.S.
  • Seoul National University, Nursing, B.S.

Younkyoung Lee / Clinical Development

I had worked as Head of Clinical Operation in global leading pharmaceutical company and currently I am in
charge of Voronoi’s clinical operation.

“Clinical study refers to tests and studies applied to humans to check pharmacological efficacy and safety of the
test drug. Every drug should be approved by government through clinical trials.
I am in charge of leading clinical development in Voronoi, checking efficacy and safety of drugs in human.
Voronoi currently has several assets in pipeline which are going through pre-clinical studies and as soon as pre-
clinical studies are over, I take the lead for clinical tests in human.
Clinical trials are not only restricted to Korea but also applied to overseas countries and foreigners. Therefore, it
is important to manage not only the project itself, but also CRO, hospitals, investigators, doctors, and staff.
Effective management skill is highly required for this job. Moreover, I need to properly manage and handle all
possible obstacles that can occur all of sudden.
For the last 20 years of leading the clinical operation in Boehringer-Ingelheim, Novonordisk, Handok, and leading
the approval process of Trajenta, Jardiance, Pradaxa, Giotrif, I learned invaluable lessons and experiences. With
this experience and know-hows, I will do my best to properly manage and lead the clinical trials of Voronoi
assets.”

  • Boehringer Ingelheim Korea, Clinical Development Director
  • Seoul National University, Public Health, M.S.
  • Seoul National University, Nursing, B.S.

Younkyoung Lee / Clinical Development

I had worked as Head of Clinical Operation in global leading pharmaceutical company and currently I am in
charge of Voronoi’s clinical operation.

“Clinical study refers to tests and studies applied to humans to check pharmacological efficacy and safety of the
test drug. Every drug should be approved by government through clinical trials.
I am in charge of leading clinical development in Voronoi, checking efficacy and safety of drugs in human.
Voronoi currently has several assets in pipeline which are going through pre-clinical studies and as soon as pre-
clinical studies are over, I take the lead for clinical tests in human.
Clinical trials are not only restricted to Korea but also applied to overseas countries and foreigners. Therefore, it
is important to manage not only the project itself, but also CRO, hospitals, investigators, doctors, and staff.
Effective management skill is highly required for this job. Moreover, I need to properly manage and handle all
possible obstacles that can occur all of sudden.
For the last 20 years of leading the clinical operation in Boehringer-Ingelheim, Novonordisk, Handok, and leading
the approval process of Trajenta, Jardiance, Pradaxa, Giotrif, I learned invaluable lessons and experiences. With
this experience and know-hows, I will do my best to properly manage and lead the clinical trials of Voronoi
assets.”